What's coming to Contemporary OBGYN® this week?
Alabama’s attorney general retracted comments he made last week suggesting criminal prosecution for women taking abortion pills for pregnancy termination. He is now saying that only providers who prescribe the pills could be prosecuted.
If approved, DARE-HRT1 would become the first FDA-approved monthly intravaginal ring to deliver both estrogen and progestin hormone therapy.
In this month's Legally Speaking column, Hindi Stohl, MD, JD, and James M. Shwayder, MD, JD, dissect a case of shoulder and abdominal dystocia during a vaginal delivery for fetal hydrops.
Findings from a study in JAMA Network Open reveal valuable insight into the way cannabis legalization has impacted the perceptions of pregnant women who use cannabis in the US.
Results of a study in JAMA Network Open sought to answer the question: Is proton pump inhibitor use during pregnancy associated with an increased risk of congenital malformations?
Many couples experiencing infertility are hesitant to get vaccined for COVID-19, resulting from misinformation on social media. A research letter in JAMA Network Open investigates the impact of COVID-19 vaccinations on artificial insemination-by-partner outcomes.
Check back soon for additional updates!
Rising endometriosis rates linked to increased pregnancy complications
May 19th 2024A new study presented at the 2024 ACOG meeting reveals a significant rise in endometriosis among pregnant women over the past 20 years, linking the condition to increased obstetric and neonatal complications.
Read More
Laparoscopic RFA linked to enhanced pregnancy outcomes in uterine fibroid patients
May 18th 2024A recent study presented at the 2024 ACOG Clinical and Scientific Meeting reveals that laparoscopic radiofrequency ablation significantly improves pregnancy outcomes for women with uterine leiomyomas.
Read More